Follow me Britton Ashley Arey, MD MBA for evidence-based perspectives on psychiatry, mental health, and the science of the mind
Conference Call Management will host a conference call to discuss results from the company's Phase 1 trial of an oral formulation of VK2735 today at 8:00 am Eastern
The Difference Between Short-Term and Long-Term GLP-1 Therapy Many patients view Wegovy as a temporary weight-loss tool, taking it for 612 months and then stopping
The goal of this combination is rarely about doubling weight loss, but rather about optimizing the environment in which that weight loss occurs
Week 1-2 (initiation at 2.5 mg): Sleep changes are minimal for most users at the starting dose
Eli Lilly, the manufacturer, has tested tirzepatide at room temperature and published clear guidelines